Dr. David B Agus M.D.
Oncologist | Medical Oncology
8700 Beverly Blvd. Los Angeles CA, 90048About
Dr. David Agus is an oncologist practicing in Los Angeles, CA. Dr. Agus specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Agus manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Univ of Pa Sch of Med, Philadelphia Pa 1992
Perelman School of Medicine University of Pennsylvania 1992
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Stromal cell oxidation: a mechanism by which tumors obtain vitamin C.
- Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer.
- Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.
- Targeting the HER-kinase axis in cancer.
- Inhibition of HER-kinase activation prevents ERK-mediated degradation of
- CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.
- PPARgamma signaling: one size fits all?
- Epithelial membrane protein-1 is a biomarker of gefitinib resistance.
- A perspective on protein profiling of blood.
- Update on HER-kinase-directed therapy in prostate cancer.
- Ductal adenocarcinoma of the prostate.
- Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies.
- Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial.
- Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
- A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer.
Dr. David B Agus M.D.'s Practice location
LOS ANGELES, CA 90064Get Direction
Dr. David B Agus M.D.'s reviews
Write ReviewRecommended Articles
- Breast Cancer Non-Profits that Make a Difference
A breast cancer diagnosis is devastating news for any woman to hear. There are so many questions. Patients are left unsure of where life is heading and the outcome. It’s a roller coaster ride. It isn’t something that the patient goes through alone either; it affects the entire family. Spouses...
- What Are the Risk Factors for Liver Cancer?
A liver cancer risk factor is something that increases your chances of getting liver cancer. Different types of cancer have different risk factors. Some risk factors can be controlled such as smoking. On the other hand, age and family history cannot be changed, which means that some risk factors...
- New Studies and Trials Show Promise for Future Ovarian Cancer Vaccination
There have been many treatment vaccines developed in the past few years for various types of cancers. They are still in the testing phases, but researchers are very excited about the preliminary results. These vaccines are working; results have looked promising. As of April 2017, recruitment has...
- Tumor DNA in Blood Used to Spot Ovarian Cancer
The longer that a cancerous tumor lies undetected in the body, the greater the risk of severe or irreversible complications. That being said, detecting cancer early can be difficult, especially if the cancer shares symptoms with other, more common diseases. Many cancers have high survival rates in...
- Limit Your Risk for Prostate Cancer with Statins
A recent study has shown that the levels of prostate specific antigen (PSA), a marker of prostate cancer, lower in men who take statin drugs. This may lower the risk of advanced prostate cancer in men, according to a study published in the Journal of the National Cancer Institute.High levels of PSA...
- What Are the Symptoms of Pancreatic Cancer?
Pancreatic cancer is one of the most common cancers in the country, and is seen in both males and females at equal rates. Based on the location in the organ, pancreatic cancer is classified into two major types – exocrine pancreatic cancer and endocrine cancer. Exocrine cancer affects the part of...
Nearby Providers
- Dr. Edwin Melencio Posadas MD8700 Beverly Blvd Los Angeles California 90048
- Boris Bagdasarian1505 Wilson Terrace Glendale California 91206
- Gayle Roberts15352 Hawthorne Blvd. Lawndale California 90260
- Dr. Jerry Kiyoharu Wada M.D.1505 WILSON TER STE 200 GLENDALE CA 91206
- Dr. Syma Iqbal M.D.1441 Eastlake Ave Los Angeles CA 90089
- Dr. Sikander Ailawadhi MD1441 Eastlake Ave Los Angeles CA 90089